King's College London

Research portal

Imaging drugs, metabolites and biomarkers in rodent lung: a DESI MS strategy for the evaluation of drug-induced lipidosis

Research output: Contribution to journalArticle

Alex Dexter, Rory T. Steven, Aateka Patel, Lea Ann Dailey, Adam J. Taylor, Doug Ball, Jan Klapwijk, Ben Forbes, Clive P. Page, Josephine Bunch

Original languageEnglish
Pages (from-to)8023-8032
Number of pages10
JournalANALYTICAL AND BIOANALYTICAL CHEMISTRY
Volume411
Issue number30
DOIs
Publication statusPublished - 1 Dec 2019

King's Authors

Abstract

Within drug development and pre-clinical trials, a common, significant and poorly understood event is the development of drug-induced lipidosis in tissues and cells. In this manuscript, we describe a mass spectrometry imaging strategy, involving repeated analysis of tissue sections by DESI MS, in positive and negative polarities, using MS and MS/MS modes. We present results of the detected distributions of the administered drug, drug metabolites, lipid molecules and a putative marker of lipidosis, di-docosahexaenoyl (22:6)-bis(monoacylglycerol) phosphate (di-22:6-BMP). A range of strategies have previously been reported for detection, isolation and identification of this compound, which is an isomer of di-docosahexaenoic (22:6 n-3) phosphatidylglycerol (di-22:6 PG), a commonly found lipid that acts as a surfactant in lung tissues. We show that MS imaging using MS/MS can be used to differentiate these compounds of identical mass, based upon the different distributions of abundant fragment ions. Registration of images of these fragments, and detected drugs and metabolites, is presented as a new method for studying drug-induced lipidosis in tissues. [Figure not available: see fulltext.]

View graph of relations

© 2018 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454